{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:44:26Z","timestamp":1790649866720,"version":"4.1.0"},"reference-count":12,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Graves disease has been associated with hematological abnormalities including anemia, thrombocytopenia, or leukopenia. Pancytopenia is a rare complication that is not often encountered. Here, we present a case of a 54-year-old woman diagnosed with Graves disease who was treated with radioiodine ablation in the setting of neutropenia. Two weeks later the patient developed pancytopenia thought to be autoimmune secondary to Graves disease. Prednisone was initiated with improvement of her pancytopenia.<\/jats:p>","DOI":"10.1210\/jcemcr\/luaf032","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:10:10Z","timestamp":1745392210000},"source":"Crossref","is-referenced-by-count":2,"title":["Rare Autoimmune Pancytopenia Due to Graves Disease"],"prefix":"10.1210","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7725-3075","authenticated-orcid":false,"given":"Ally W","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism at Zucker School of Medicine at Hofstra\/Northwell , Manhasset, NY 11030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeti","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolism at Maimonides Medical Center , Brooklyn, NY 11219 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Etra","sequence":"additional","affiliation":[{"name":"The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira R","family":"Saul","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, James J. Peters Department of Veterans Affairs Medical Center , Bronx, NY 10468 ,","place":["USA"]},{"name":"Department of Endocrinology, Diabetes and Bone Disease at Icahn School of Medicine at Mount Sinai , New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"9856","key":"2025042313221372100_luaf032-B1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(12)61768-1","article-title":"Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial","volume":"380","author":"Coles","year":"2012","journal-title":"Lancet"},{"issue":"9856","key":"2025042313221372100_luaf032-B2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(12)61769-3","article-title":"Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial","volume":"380","author":"Cohen","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"2025042313221372100_luaf032-B3","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.V104.11.2645.2645","article-title":"Prolonged severe pancytopenia and myelodysplastic features following alemtuzumab therapy in patients with cutaneous T-cell lymphomas","volume":"104","author":"Gibbs","year":"2004","journal-title":"Blood"},{"key":"2025042313221372100_luaf032-B4","doi-asserted-by":"crossref","first-page":"1179547618781090","DOI":"10.1177\/1179547618781090","article-title":"Graves disease causing pancytopenia: case report and literature review","volume":"11","author":"Pincet","year":"2018","journal-title":"Clin Med Insights Case Rep"},{"issue":"1","key":"2025042313221372100_luaf032-B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12701\/yujm.2013.30.1.47","article-title":"A case of pancytopenia with hyperthyroidism","volume":"30","author":"Kim","year":"2013","journal-title":"Yeungnam Univ J Med"},{"key":"2025042313221372100_luaf032-B6","doi-asserted-by":"crossref","first-page":"194542","DOI":"10.1155\/2013\/194542","article-title":"Graves' disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature","volume":"2013","author":"Naji","year":"2013","journal-title":"Case Rep Med"},{"issue":"1","key":"2025042313221372100_luaf032-B7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s42000-020-00227-5","article-title":"Graves' hyperthyroidism-related pancytopenia: a case report with literature review","volume":"20","author":"Scappaticcio","year":"2021","journal-title":"Hormones (Athens)"},{"issue":"4","key":"2025042313221372100_luaf032-B8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/thy.2006.16.403","article-title":"Pancytopenia in untreated patients with Graves' disease","volume":"16","author":"Lima","year":"2006","journal-title":"Thyroid"},{"issue":"5","key":"2025042313221372100_luaf032-B9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2265.2008.03382.x","article-title":"Characterization of the anemia associated with Graves' disease","volume":"70","author":"Gianoukakis","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025042313221372100_luaf032-B10","first-page":"23","article-title":"Hyperthyroidism with pancytopenia: a case report and literature review","volume":"1","author":"Low","year":"2009","journal-title":"Formosan J Endocrinol Metab"},{"issue":"17","key":"2025042313221372100_luaf032-B11","first-page":"807","article-title":"Pancytop\u00e9nie r\u00e9solutive par le traitement d'une hyperthyro\u00efdie [Pancytopenia resolved by the treatment of hyperthyroidism]","volume":"24","author":"Duquenne","year":"1995","journal-title":"Presse Med"},{"key":"2025042313221372100_luaf032-B12","doi-asserted-by":"crossref","first-page":"bcr2017223887","DOI":"10.1136\/bcr-2017-223887","article-title":"Pancytopenia: a rare complication of graves' disease","volume":"2018","author":"Garla","year":"2018","journal-title":"BMJ Case Rep"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/6\/luaf032\/62989712\/luaf032.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/3\/6\/luaf032\/62989712\/luaf032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T17:22:19Z","timestamp":1745428939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luaf032\/8118074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,4,18]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luaf032","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,4,18]]},"article-number":"luaf032"}}